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Background: Diabetes complications have been increasingly prevalent among type 2 diabetics
during the past decades causing high rates of morbidity and mortality. Measures of the
prevalence of diabetes complications will lead to preventive decisions and planning of health
care. The main objective of this study was to assess the prevalence rates of complications
in Type 2 diabetics in two Diabetes Centers in Dubai. Methods: A cross-sectional descriptive
analytical study conducted among type 2 diabetics attending diabetes centers in Dubai. Data
was collected form secondary source using patients’ records from two diabetes centers involved
in the study. Random sampling technique was used to collect 150 patients proportionally
allocated according to the total patients (4700 attending patients) available in the two diabetes
centers. Data obtained was analyzed using SPSS v.22. Descriptive statistics were calculated
(mean, standard deviation, and percentages). Chi-square test was used to compare frequencies
between groups. The signiﬁcance level was set at 0.05. Results: The study showed that the
most dominant prevalence type of complications were: Hyperlipidemia (84%), Neuropathy
(34%), Dyslipidemia (32%), Retinopathy (28%), Lethargy (21.3%), and Nephropathy (16.7%).
The associations made between three variables each separately (Date of First Visit, HbA1 c,
and Fasting Blood Glucose) with the prevalence type of complications, showed signiﬁcant
differences in some types: Dyslipidemia, Hyperlipidemia, Neuropathy, Retinopathy, and Joint &
Bone pain. Conclusions: There is a reasonable correlation between different variables and the
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prevalence of complications among the diabetic population, thus studies should always follow
up on this issue in order to have clear associations to prevent complications from occurring in
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1. Introduction
The term diabetes refers to a group of metabolic disorders caused by continuous
hyperglycemia resulting from defects in insulin secretion, action, or both (Craig, et al.,
2014). Diabetes is classiﬁed into different types based on the type of insulin defection.
The classiﬁcation of diabetes includes two main categories, type 1 diabetes, and type
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2 diabetes (Craig, et al., 2014). Type 1 diabetes results from the deﬁciency of insulin
secretion, and on other hand type 2 diabetes results from a combination of resistance
to insulin action and an inadequate compensatory insulin secretory response from the
cells which is basically an ineffective use of insulin by the body (WHO, 2016; Craig, et al.,
2014). The other type of diabetes is uncommon and comes as result of a certain
condition such as gestational diabetes, which refers to hyperglycemia with onset during
pregnancy, it’s a speciﬁc genetically deﬁned form of diabetes (American Diabetes
Association, 2010).
Health complications associated with Diabetes Miletus (DM) are a growing concern
for both developing and developed countries. Epidemiological studies worldwide have
shown an alarming increase in the incidences of DM. According to WHO estimates, DM
is ranked to be the 8𝑡ℎ leading cause of mortality in 2015 and is projected to turn into
the 7𝑡ℎ by 2020. This is serious considering its impact on the quality of life and the
substantial economic burden on the health care system (Abdul Razzak, et al., 2017).
The UAE has witnessed a tremendous economic and ﬁnancial development with the
discovery of oil and natural gas over the past three decades. This rapid development has
transitioned the UAE population into one of the highest income levels worldwide, which
signiﬁcantly contributed to changes in population lifestyle and health outcomes. The
UAE has one of the highest rates of type 2 diabetes in the world, with estimates of being
in the top ﬁve (Sreedharan, et al., 2015). The prevalence rate of DM 2 was reported to be
23%, with 6.6-14.6% of the residents remained undiagnosed (ﬁnd out year) (Herbert F
Jelinek, et al., 2017). Furthermore, 5.4% of Emirati children and adolescents were found
to be in the prediabetes state (Al Amiri, et al., 2015). Proper management of diabetes and
lifestyle interventions aimed at various risk factors such as obesity have been shown
to be effective in preventing or delaying the onset of the disease and lowering the its
complications risks.
Poor management of diabetes mellitus type 2 can lead to various complications
that affect the mortality and morbidity rates. DM 2 complications are classiﬁed into
two types, short-term impairments and complications and long-term impairment (Leontis & Hess-Fischl, 2016). The short-term complications associated with type 2 diabetes mellitus include anxiety, heart palpitations, and loss of concentration or dizziness
(Leontis & Hess-Fischl, 2016). Long-term complications can be either micro- or macrovascular complications. The Micro-vascular complications include retinopathy, neuropathy, nephropathy, and cataracts (McCulloch, 2016). The macro-vascular complications
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include strokes, heart attacks and peripheral vascular disease (Leontis & Hess-Fischl,
2016).
Despite the alarming rise in the occurrence of DM 2 and associated complications
in the UAE, very few studies have explored the prevalence of complications associated
with DM 2 in the UAE. The prevalence studies were conducted in different emirates and
cities within the UAE, particularly in Al Ain, Sharjah and Abu Dhabi. To our Knowledge,
no complications incidence rates were reported for the emirate of Dubai (Khandoker,
et al., 2017; Alsafar, et al., 2012). Therefore, this study was undertaken to assess the
prevalence of diabetes’ complications in the emirate of Dubai to ﬁll the gap in the
existing knowledge on DM 2 and inform future research, management and intervention
programs.

2. Methods
A cross sectional study was conducted to assess the prevalence of complications in
type 2 diabetics from two well-known diabetes centers in Dubai, the Diabetes and
Endocrine and the RAK Diabetes Center. Permissions were obtained from the Diabetes
Centers in Dubai to review the patients records and extract the needed information
for this study. Letters from the Ofﬁce of Research at Zayed University were sent to the
centers to allow students collect the data from their patients records. Consents were
signed by the centers to assure conﬁdentiality. Ethical approval was obtained from
Zayed University ethical committee and all information used in this study were handled
in complete terms of anonymous and conﬁdentiality.
A sample of 150 patient records were randomly selected from a total of 4700 patients
attending to the two diabetes centers. Records of adults with type 2 diabetes aged
18 years old and above were reviewed and included in this study, whereas records
for pregnant women, children and patients with type 1 diabetes were excluded. The
information extracted from the records include: sociodemographic data (age, gender
and education), anthropometric measurements (weight, height and BMI), recent lab
results (HbA1c, Fasting Blood Glucose, Albumin, Creatinine, ALT, AST, total Cholesterol,
HDL, LDL and Triglycerides), types of complications present (Dyslipidemia, Hyperlipidemia, Retinopathy, Neuropathy, Nephropathy, Foot Complications, Weight Fluctuations, Numbness of feet and hands, Muscles cramp, Joint and Bone pain, Lethargy,
Chronic pain, and others) and the date of the ﬁrst visit to the center.
DOI 10.18502/ajne.v4i2.5161
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Data collected from the records by using data sheets special for each patient record
were entered and analysed using the Statistical Package for the Social Sciences (SPSS)
version 22. (SPSS Inc., Chicago IL). Frequency analyses were run for all variables.
Bivariate analyses were performed to identify signiﬁcant differences. Chi-square values
were used to measure association between complications and date of ﬁrst visit to the
centre, HbA1c, and Fasting Blood Glucose.

3. Results
The study sample age was ranged between 19-79 years old with Mean (SD) 50.42(14.1)
for males and 51.6(16.3) for females. Table 1 shows the sociodemographic characteristics
of the sample. According to the age group analysis, the highest percentage (38%) was
from the age group of 46-60 years old, and the lowest percentage was the age group of
people aged less than 30 years. Males made up the majority of the sample total (63.3%),
and the entire sample is located in Dubai. The level education was classiﬁed by both
centers into: Low: Did not seek education; Medium: High school; High: University &
more. More than half (62%) of the sample were highly educated people, 22.7% those
graduated from high school only, and 15.3% had low level education (table 1).
Table 1: Sociodemographic Characteristics.
Variable

N (150)

%

The Diabetes & Endocrine Center

82

54.7%

RAK Diabetes Center

68

45.3%

18 – 30 years

16

10.7%

31 – 45 years

37

24.7%

46 – 60 years

57

38.0%

> 60 years

40

26.7%

Female

55

36.7%

Male

95

63.3%

Low: Did not seek education

23

15.3%

Medium: High school

34

22.7%

High: University & more

93

62.0%

Center Name

Age

Gender

Education level

Most of the patients were overweight and obese. About one third (32%) of the sample
were obese and 41% were overweight as shown in Figure 1.
DOI 10.18502/ajne.v4i2.5161

Page 55

Haleama Al Sabbah et al

Arab Journal of Nutrition and Exercise

Figure 1: Weight status of the sample.

Tables 2& 3 show the mean, standard deviation, minimum, and maximum of the lab
tests for HbA1 c, blood lipids proﬁle, creatinine, albumin ALT and AST by gender.
The means for the HbA1 c level were 7.42 for males and 7.45 for females. The FBG
was 221.1mg/dL for males and 215.4 mg/dL for females. The total cholesterol mean was
163.38 for males and 182.1 for females. The HDL mean was 41.5mg/dL for males and
44.1mg/dL for females. Both males and females were at the borderline of low HDL. The
LDL mean was 99.72 mg/dL for males (at the borderline), 110.7 mg/dL (high) for females.
Triglycerides was 141.38 mg/dL for males and 126.36 mg/ dL for females (table 2).
Table 2: Mean and Standard Deviation of Blood Glucose and Lipid Proﬁle by Gender.
Variable

Male (N=95)

HbA1 c
Fasting Blood Glucose
Total Cholesterol

Female (N=55)

Mean (SD)

Min-Max

Mean (SD)

Min-Max

7.42(1.3)

4.5-11.5

7.45(1.4)

5.2-12

221.1(53.7)

105-408

215.4(53.0)

108-402

163.38(37.7)

96-352

182.1(45.6)

86-379

HDL

41.5(14.04)

19-95

44.1(15.48)

17-81

LDL

99.72(35.66)

42-246

110.7(42.2)

31-217

141.38(61.8)

41-413

126.36(51.1)

35-316

Triglycerides

Table 3: Mean and Standard for other Lab Tests by Gender.
Variable

DOI 10.18502/ajne.v4i2.5161

Male

Female

N (95)

Mean (SD)

Min-Max

N (55)

Mean (SD)

Min-Max

Albumin

42

3.42(1.6)

1-8

20

3.74(1.46)

1.3-8.3

Creatinine

69

1.36(1.3)

0.23-7.2

30

1.36(1.14)

0.60-5.8

ALT

68

26.82(13.8)

8-80

40

22.97(13.9)

10-89

AST

56

23.7(10.1)

11-56

37

25.49(16.3)

8-84
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All lab values got high counts of normal results than abnormal except fasting blood
glucose, HbA1 c and albumin. From the total sample (n=150) 7 (4.7%) only had normal
FBG (Fasting blood glucose) values and 143 (95.3%) had abnormal values. According to
HbA1 c, 53 (35.5%) had normal values and 97 (64.7%) abnormal from the total sample
(n=150). Also, 28 (45.2%) had normal values of Albumin and 34 (54.9%) are abnormal.
Table 4: Cut off points of lab values for management of diabetes.
Lab values
Total cholesterol (ADA, 2016)

Normal

Abnormal

< 200 mg/dL

≥ 200 mg/dL

HDL (ADA, 2016)

> 40 mg/dL

≤ 40 mg/dL

LDL (ADA, 2016)

< 100 mg/dL

≥ 100 mg/dL

Triglycerides

< 150 mg/dL

≥ 150 mg/dL

Fasting blood glucose (ADA, 2016)

< 130 mg/dL

≥ 130 mg/dL

< 7%

≥ 7%

3.5-5.5g

< 3.5g, > 5.5g

0.6-1.3 mg/dL

> 1.3, <0.6 mg/dL

ALT (FDA, 2015)

0-30 U/L

> 30 U/L

AST (FDA, 2015)

0-40 U/L

> 40 U/L

HbA1 c (ADA, 2016)
Albumin (FDA, 2015)
Creatinine (FDA, 2015)

Table 5: Lab values normal and abnormal counts / Frequencies.
Lab values

Normal

Abnormal

N

%

N

%

Total cholesterol

122

81.3

28

18.7

HDL

74

49.3

76

50.7

LDL

87

58.0

63

42.0

Triglycerides

105

70.5

44

29.5

Fasting blood glucose

7

4.7

143

95.3

HbA1 c

53

35.5

97

64.7

Albumin

28

45.2

34

54.9

Creatinine

70

72.2

27

27.9

ALT

82

75.9

26

24

AST

84

90.3

9

9.7

The most dominant complication is Hyperlipidemia (84%), followed by Neuropathy
(34%), Dyslipidemia (32%), Retinopathy (28%), Lethargy (21.3%), Nephropathy (16.7%),
Joint & Bone pain (16%), Numbness of feet and hands (12.7%), Foot complications (12%),
Other complaints (11%), Weight Fluctuations (9.3%), Chronic pain (8.7%), and Muscle
cramps (7.3%).
Table 7 shows the association between date of ﬁrst visit to the center and type
of complication. Dyslipidemia (0.013), Hyperlipidemia (0.042), Neuropathy (0.032), and
Joint & Bone pain (0.016) showed a signiﬁcant association with the date of ﬁrst visit
DOI 10.18502/ajne.v4i2.5161
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Table 6: Prevalence of Complications of Type 2 Diabetes.
Type of Complication

N

%

Dyslipidemia

49

32%

Hyperlipidemia

126

84%

Retinopathy

42

28%

Neuropathy

51

34%

Nephropathy

25

16.7%

Foot Complications

18

12%

Weight Fluctuations

14

9.3%

Numbness of feet and hands

19

12.7%

Muscles cramp

11

7.3%

Joint and Bone pain

24

16%

Lethargy

32

21.3%

Chronic pain

13

8.7%

Other complaints

17

11.3%

that was considered as the estimate for disease duration. Dyslipidemia: Those who
got their ﬁrst date of visit to the centers in 2010 and before got the highest valid
percentage (48.5%) among the three categories of years time frame. Between 20112013, 40% got dyslipidemia, and those who visited the center from 2014 and on got
the least percentage 22.1%. Hyperlipidemia: 90.9% from those who visited the centers
in 2014 till the date of data collection for this study suffered from hyperlipidemia, 80%
from those visited the centers between 2011-2013, and 72.7% who’s ﬁrst visit was in
2010 and before. Neuropathy: The highest percentages are among those visited the
centers in 2014 till the date of data collection for this study (41.6%), followed by 36.4%
in 2010 and before, and 17.5% between 2011 and 2013.
Joint & Bone pain: those visited the centers in 2010 and before had 27.3% suffering
from joint and bone pain, 22.5% in 2011-2013, and 7.8% in 2014-2017.
Moreover, table 7 shows the association between HbA1 c and type of complication. A
signiﬁcant difference found between HbA1 c levels and Dyslipidemia (0.008), Hyperlipidemia (0.037), and Retinopathy (0.050). Results shows no signiﬁcant difference between
fasting blood glucose and types of complications, but this might be because of the
small sample number due to limitations and other factors that will be discussed in the
discussion.
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16

24

12

12

5

4

1

4

4

9

11

2

4

Hyperlipidemia

Retinopathy

Neuropathy

Nephropathy

Foot Complications

Weight Fluctuations

Numbness of feet and hands

Muscles cramp

Joint and Bone pain

Lethargy

Chronic pain

Other complaints

N

12.1

6.1

33.3

27.3

12.1

12.1

3

12.1

15.2

36.4

36.4

72.7

48.5

%

4

1

10

9

4

8

6

5

10

7

10

32

16

N

10

2.5

25

22.5

10

20

15

12.5

25

17.5

25

80

40

%

2011-2013

9

10

11

6

3

7

7

9

10

32

20

70

17

N

%

11.7

13

14.3

7.8

3.9

9.1

9.1

11.7

13

41.6

26

90.9

22.1

≥ 2014

0.951

0.134

6

7

10

8

0.016
0.066

1

6

6

8

0.238

0.241

0.215

0.992

7

18

0.032
0.246

20

49

0.042
0.477

10

Nor.

0.013

P-value

Duration of disease Date of First Visit (in years)

≤ 2010

Dyslipidemia

Type of complication

11

6

22

16

10

13

8

10

18

33

22

77

39

Abn.

17

13

32

24

11

19

14

18

25

51

42

26

49

Yes

HbA1c

0.997

0.144

0.586

0.823

0.059

0.714

0.536

0.389

0.401

1

1

1

0

0

2

0

1

1

4

3

0.050
0.994

6

3

Nor.

0.037

0.008

P-value

16

12

31

24

11

17

14

17

24

47

39

120

46

Abn.

17

13

32

24

11

19

14

18

25

51

42

126

49

Yes

0.801

0.588

0.641

0.237

0.446

0.195

0.385

0.849

0.863

0.186

0.370

0.899

0.56

P-value

Fasting blood glucose

Table 7: Associations between the type of complication and Duration of disease, HbA1c, and fasting blood glucose.
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4. Discussion
This study was aimed to identify the prevalence of complications in type 2 diabetics
from diabetes centers in Dubai. In addition, it assessed the associations between the
type of complication and the duration of the disease, the HbA1c and the Fasting blood
glucose. The largest percentages fall in the age group of 46-60 years old (38%), and
those aged 60 years and above (26.7%). A study conducted in UAE at elderly homebased primary care (EHBPC) at Dubai Health Authority from 2011- 2013, showed that
diabetes is more dominant in elderly. It found that one of the highest common prevalent
diseases was diabetes mellitus, it accounts for 52.4% from the sample studied (n=206)
(AlShaali & Jaziri, 2015).
According to the level of education, 62% were classiﬁed as high, that indicates a
university graduate or more, 22.7% falls in the medium level, which is up to high school
only, and 15.3% were classiﬁed low, that indicates those who never received any type of
education. Those classiﬁcations were made based on both centers’ way of recording.
The mean of HbA1 c level is 7.4%, which indicates that most of the sample have a
poor glycemic control. For the fasting blood glucose the mean differ in both gender
but somehow close. Males mean FBG is 221.1 mg/dL and females mean FBG is 215.4
mg/dL. Both genders FBG is considered very high compared to the recommendation
cut off of management < 130 mg/dL (ADA, 2016).
For the lipid proﬁle, the total cholesterol mean for males was 163.38 and 182.1 for
females, which shows that most levels fall within the acceptable range < 200mg/dL
(ADA, 2016). HDL mean (Males: 41.5mg/dL, Females: 44.1 mg/dL) for both were at the
borderline or at risk of being under the recommended level > 40mg/dL (ADA, 2016).
LDL mean in males (99.72 mg/dL) is at the borderline of the cutoff point of management
< 100mg/dL (ADA, 2016). Whereas females mean average (110.7 mg/dL) is considered
high and over the recommended level. For triglycerides the mean for both genders
(Males141.38 mg/dL, Females: 126.36 mg/dL) indicates that the levels are mostly normal
under the cutoff point < 150mg/dL (ADA,2016). The other lab values mean such as
albumin, creatinine, ALT, and AST of both genders are considered acceptable and fall
within the recommendations. In addition, each lab value showed some results in both
extremes (minimum-maximum).
This study showed different prevalence of the type of complications among the total
sample. The most prevalent type of complication is Hyperlipidemia, which accounts
for 84% of the population studied equivalent to 126 from 150 total sample. The other
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complication percentages from the total sample are Neuropathy (34%), Dyslipidemia
(32%), Retinopathy (28%), Lethargy (21.3%), and Nephropathy (16.7%), Joint & Bone pain
(16%), Numbness of feet and hands (12.7%), Foot complications (12%), Other complaints
(11%), Weight Fluctuations (9.3%), Chronic pain (8.7%), and Muscle cramps (7.3%). The
prevalence of complications result due to poor control of the disease and delay in
seeking care as mentioned by Gavan (2016) regarding what contributes to the development of complications, and according to Molinaro & Dauscher (2017), poor control of
the disease results in all type of complications that includes retinopathy, neuropathy,
nephropathy, and cardiovascular diseases.
The second part of this study aim was to assess the associations between different
factors and the prevalence of complications. One of the associations was between
HbA1 c levels and the type of complications prevalent. Results have showed a signiﬁcant
difference between HbA1 c and three types of complications: Dyslipidemia (0.008),
Hyperlipidemia (0.037), Retinopathy (0.050), and a borderline with Muscle cramp (0.059).
HbA1 c is a critical factor that inﬂuences the development of complications. To delay the
onset of any further complication of the disease, the glycemic control should always
be at an acceptable level (Ab Hamid, et al., 2016). The 2𝑛𝑑 association was assessed
between the date of ﬁrst visit and type of complication present to identify if the duration
of the disease inﬂuence the incidence of a certain type of complication. Analysis showed
signiﬁcant difference in four types of complications: Dyslipidemia (0.013), Hyperlipidemia
(0.042), Neuropathy (0.032), and Joint & Bone pain (0.016). The Centers lack the record
of disease duration, so date of ﬁrst visit was collected as an indicator for the duration
of the disease. Within this condition some types showed insigniﬁcant, but if duration
record was found, the association would be more clear and might show other signiﬁcant
variables. The 3𝑟𝑑 association was assessed between fasting blood glucose and the type
of complications present. The analysis showed no signiﬁcant difference but that may
be due to the small sample number. According to lab values frequencies of FBG, the
count of abnormalities was very high (95.3%) compared to the normal count (4.7%).
The most important limitations that might inﬂuenced the results of this study were;
the sample size was relatively small (150 record), the time given by the diabetes centers
to have access to their records was very constricted. Access to records was only for one
day a week and should not be more than 4 hours according to the diabetes centers
permission letter to access their patients records. In addition, missing information for
important variables in some records.
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5. Conclusion and Recommendations
The most prevalent types of complications in descending order are Hyperlipidemia
(84%), followed by Neuropathy (34%), Dyslipidemia (32%), Retinopathy (28%), Lethargy
(21.3%), and Nephropathy (16.7%) among 150 patients records with type 2 diabetics in
Diabetic Centers in Dubai. High percentages of overweight (40.4%) and obesity (31.1%)
are found among the total sample, and the most dominant age group is within the range
from 46 to 60 years old (38%). According to the association made between the Date of
First Visit and complications, a signiﬁcant difference appeared in Dyslipidemia (0.013),
Hyperlipidemia (0.042), Neuropathy (0.032), and Joint & Bone pain (0.016). On the other
hand, the association between HbA1 c and type of complications showed signiﬁcant
differences in Dyslipidemia (0.008), Hyperlipidemia (0.037), Retinopathy (0.050), and
muscle cramps (0.059) was on the borderline. Moreover, the association between the
fasting blood glucose showed no signiﬁcant difference in all types of complications,
whereas the counts of abnormal FBG levels are higher than the normal.
Lack of important information in the center’s records (e.g: the time of onset of
ﬁrst complication and the duration of the disease). Knowing such information could
help in assessing the associations between the disease and other factors. Therefore,
recording these types of information are highly recommended which will help in taking
the effective measures to prevent the complications and follow up studies to collect
information and create clear associations. Moreover, since there are lack of studies
involved in studying the prevalence of diabetes complications in Dubai, diabetes centers
should be more collaborative with the research ﬁeld in order to increase the beneﬁts
for their patients and improve the services provided in the health care centers.
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